Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

PPD Agrees To Buy And Sell Businesses

by Alexander H. Tullo
April 13, 2009 | A version of this story appeared in Volume 87, Issue 15

Contract research and drug development firm PPD has agreed to sell its Piedmont Research Center to the contract R&D firm Charles River Laboratories for $46 million in cash. Located in North Carolina, the center provides preclinical research and evaluates anticancer agents. To boost its remaining operations, PPD has acquired Magen BioSciences for $14.5 million. Waltham, Mass.-based Magen develops dermatologic therapies for psoriasis, atopic dermatitis, and acne. The biotech firm has an exclusive license to develop and commercialize preclinical compounds discovered by Eli Lilly & Co. for dermatologic therapeutics.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.